Patients should contact their GP or diabetes specialist nurse urgently if they experience: Widespread or severe itching that affects multiple areas of the body or significantly impacts quality of life and sleep Accompanying rash, hives (urticaria), or skin changes such as blistering, peeling, or discolouration Swelling of the face, lips, tongue, or throat , which may indicate angioedema Difficulty breathing, wheezing, or chest tightness , suggesting a potential anaphylactic reaction Persistent itching at injection sites that does not resolve within a few days or worsens over time Signs of infection at injection sites, including increased warmth, pus, or spreading redness Itching with yellowing of the skin or eyes (jaundice) , dark urine, pale stools, or right upper abdominal pain, which could indicate gallbladder or liver problems Anaphylaxis is a rare but serious hypersensitivity reaction that requires immediate emergency care

Individuals with type 1 diabetes rely on lifelong insulin administration, while those with type 2 diabetes may require insulin if other treatments fail
Initially approved for type 2 diabetes, they are now also FDA-approved for weight management, cardiovascular risk reduction, obstructive sleep apnea, and metabolic-associated liver disease (steatohepatitis)
The effects of bariatric surgery and gastrectomy on the absorption of drugs, vitamins, and mineral elements
Whether cagrilintide dosage with retatrutide specifically emerges as a validated approach remains to be seen
Choosing the right product: Opt for serums and creams with a GHK-Cu concentration of at least 1%